Literature DB >> 6120716

Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranolol.

S Sonkodi, E Agabiti-Rosei, R Fraser, B J Leckie, J J Morton, A M Cumming, V P Sood, J I Robertson.   

Abstract

1 Upright tilting in normal volunteers caused increases in plasma active and total renin, angiotensin II and aldosterone; a slight but significant fall in inactive renin accompanied these changes. 2 The alterations in the renin-angiotensin-aldosterone system on tilting took up to 1 h upright to become fully established. 3 Large intravenous doses of propranolol or metoprolol attenuated, without abolishing, the rises in active renin, angiotensin II, and aldosterone; the attenuation was most evident soon after tilting and was largely overcome by 1 h upright. Inactive renin did not fall significantly after beta-adrenoceptor blockade. 4 Intravenous frusemide caused immediate rises in plasma active, total and inactive renin, angiotensin II, and aldosterone, which then declined over 2 h despite increasing cumulative sodium losses. 5 Intravenous propranolol or metoprolol attenuated, without abolishing, these early increases in the components of the renin-angiotensin-aldosterone system after frusemide. 6 Prior oral metoprolol or propranolol, while significantly slowing the heart, did not limit the early rise in plasma angiotensin II following intravenous frusemide. 7 Thus in contrast to previous workers, we did not find that propranolol eliminated the response of the renin-angiotensin system to upright tilting; in part this difference appeared to be due to the longer tilt we employed. 8 Also in contrast to earlier work, we found attenuation by both intravenous propranolol and metoprolol of the immediate rise in renin after intravenous frusemide.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6120716      PMCID: PMC1402119          DOI: 10.1111/j.1365-2125.1982.tb01384.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  29 in total

1.  Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states.

Authors:  G Düsterdieck; G McElwee
Journal:  Eur J Clin Invest       Date:  1971-11       Impact factor: 4.686

2.  Plasma renin in idiopathic orthostatic hypotension: differential response in subjects with probable afferent and efferent autonomic failure.

Authors:  D R Love; J J Brown; R H Chinn; R H Johnson; A F Lever; D M Park; J I Robertson
Journal:  Clin Sci       Date:  1971-10       Impact factor: 6.124

3.  Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

Authors:  F R Bühler; J H Laragh; E D Vaughan; H R Brunner; H Gavras; L Baer
Journal:  Am J Cardiol       Date:  1973-09-20       Impact factor: 2.778

4.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

5.  Effect of posture on the metabolic clearance rate, plasma concentration and blood production rate of aldosterone in man.

Authors:  H M Balikian; A H Brodie; S L Dale; J C Melby; J F Tait
Journal:  J Clin Endocrinol Metab       Date:  1968-11       Impact factor: 5.958

6.  Mechanism of renin release following furosemide diuresis in rabbit.

Authors:  P Meyer; J Menard; N Papanicolaou; J M Alexandre; C Devaux; P Milliez
Journal:  Am J Physiol       Date:  1968-10

7.  Falsely high plasma potassium values in patients with hyperaldosteronism.

Authors:  J J Brown; R H Chinn; D L Davies; R Fraser; A F Lever; R J Rae; J I Robertson
Journal:  Br Med J       Date:  1970-04-04

8.  Effect of angiotensin and of frusemide on plasma aldosterone, corticosterone, cortisol and renin in man.

Authors:  R Fraser; V H James; J J Brown; P Isaac; A F Lever; J I Robertson
Journal:  Lancet       Date:  1965-11-13       Impact factor: 79.321

9.  Plasma renin concentration in relation to changes in posture.

Authors:  J J Brown; D L Davies; A F Lever; D McPherson; J I Robertson
Journal:  Clin Sci       Date:  1966-04       Impact factor: 6.124

10.  The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects.

Authors:  H R Brunner; L Baer; J E Sealey; J G Ledingham; J H Laragh
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

View more
  5 in total

Review 1.  Newer beta blockers and the treatment of hypertension.

Authors:  D McAreavey; R Vermeulen; J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

Review 2.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

Review 3.  Cardio-respiratory effects of change of body position.

Authors:  T J Coonan; C E Hope
Journal:  Can Anaesth Soc J       Date:  1983-07

4.  Hormonal and blood pressure responses to tilting in beta-blocked essential hypertension treated with felodipine or prazosin.

Authors:  B Jackson; B P McGrath; C I Johnston
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.